Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study

[1]  A. Pollard,et al.  Strategies for typhoid conjugate vaccines in endemic nations - Authors' reply. , 2021, The Lancet. Infectious diseases.

[2]  N. Arinaminpathy,et al.  Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine , 2021, Nature Communications.

[3]  P. Diggle,et al.  Intestinal Perforations Associated With a High Mortality and Frequent Complications During an Epidemic of Multidrug-resistant Typhoid Fever in Blantyre, Malawi , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  L. Hampton,et al.  Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  A. Ikram,et al.  Emergence of Novel Mutations in Extensively Drug-Resistant Salmonella enterica Serovar Typhi from Pakistan , 2020, Antimicrobial Agents and Chemotherapy.

[6]  Jessica C. Chen,et al.  Update on Extensively Drug-Resistant Salmonella Serotype Typhi Infections Among Travelers to or from Pakistan and Report of Ceftriaxone-Resistant Salmonella Serotype Typhi Infections Among Travelers to Iraq — United States, 2018–2019 , 2020, MMWR. Morbidity and mortality weekly report.

[7]  N. Arinaminpathy,et al.  Childhood vaccines and antibiotic use in low- and middle-income countries , 2020, Nature.

[8]  F. Qamar,et al.  Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan , 2020, Vaccine.

[9]  Alan D. Lopez,et al.  Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis , 2020, BMC Medicine.

[10]  S. Baker,et al.  Efficacy of Typhoid Conjugate Vaccine in Nepal: An Interim Analysis of a Participant-and Observer-Blinded Randomized Phase III Trial , 2019, The New England journal of medicine.

[11]  K. Neuzil,et al.  Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study , 2019, The Lancet. Infectious diseases.

[12]  David L. Smith,et al.  The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The Lancet. Infectious diseases.

[13]  R. Yaesoubi,et al.  Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  S. Qureshi,et al.  Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  I. Bogoch,et al.  Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance. , 2019, The Lancet. Infectious diseases.

[16]  A. Pollard,et al.  A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid , 2018, PLoS neglected tropical diseases.

[17]  S. Nair,et al.  Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins , 2018, mBio.

[18]  I. Bogoch,et al.  Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study , 2018, The Journal of infectious diseases.

[19]  Forrest W. Crawford,et al.  The burden of typhoid fever in low- and middle-income countries: A meta-regression approach , 2017, PLoS neglected tropical diseases.

[20]  W. Edmunds,et al.  A review of typhoid fever transmission dynamic models and economic evaluations of vaccination , 2015, Vaccine.

[21]  G. Kang,et al.  Predicting the Impact of Vaccination on the Transmission Dynamics of Typhoid in South Asia: A Mathematical Modeling Study , 2014, PLoS neglected tropical diseases.

[22]  J. Farrar,et al.  Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure , 2013, eLife.

[23]  J. Farrar,et al.  The Microbiological and Clinical Characteristics of Invasive Salmonella in Gallbladders from Cholecystectomy Patients in Kathmandu, Nepal , 2012, PloS one.

[24]  Organización Mundial de la Salud.  Typhoid vaccines: WHO position paper. , 2008, Releve epidemiologique hebdomadaire.

[25]  J. Wain,et al.  The emergence of antibiotic resistance in typhoid fever. , 2004, Travel medicine and infectious disease.

[26]  Z. Bhutta,et al.  Impact of age and drug resistance on mortality in typhoid fever. , 1996, Archives of disease in childhood.

[27]  H. Dupont,et al.  Typhoid fever: pathogenesis and immunologic control. , 1970, The New England journal of medicine.